The Food and Drug Administration on Wednesday shared guidance on how developers can seek emergency use authorization for monkeypox tests. The agency said it intends to prioritize review of EUA ...
Veru (NASDAQ:VERU) said it plans to file an emergency use authorization (EUA) for its medicine sabizabulin to treat COVID-19 in Q2 after U.S. Food and Drug Administration (FDA) considered the data ...
Veru Inc. (NASDAQ:VERU) is a great speculative biotech to look into. That's because it not only reported positive results from a phase 3 study using sabizabulin to treat high-risk hospitalized ...
With the FDA granting emergency use authorization (EUA) to Invivyd’s lead candidate, a monoclonal antibody (mAb) designed to prevent COVID-19 in immunocompromised adults and adolescents, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback